4-2941647-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The NM_001291978.2(NOP14):āc.2134A>Gā(p.Met712Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,613,440 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_001291978.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NOP14 | NM_001291978.2 | c.2134A>G | p.Met712Val | missense_variant | 15/18 | ENST00000416614.7 | NP_001278907.1 | |
NOP14 | NM_003703.3 | c.2134A>G | p.Met712Val | missense_variant | 15/19 | NP_003694.1 | ||
NOP14 | NM_001291979.2 | c.2134A>G | p.Met712Val | missense_variant | 15/17 | NP_001278908.1 | ||
NOP14-AS1 | NR_015453.2 | n.2697+2855T>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NOP14 | ENST00000416614.7 | c.2134A>G | p.Met712Val | missense_variant | 15/18 | 1 | NM_001291978.2 | ENSP00000405068.2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152116Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000805 AC: 2AN: 248462Hom.: 0 AF XY: 0.00000743 AC XY: 1AN XY: 134602
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461206Hom.: 0 Cov.: 33 AF XY: 0.00000688 AC XY: 5AN XY: 726858
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152234Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74440
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 23, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at